Mirae Asset Global Investments’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-28,531
Closed -$1.47M 2663
2022
Q3
$1.47M Buy
28,531
+8,486
+42% +$351K ﹤0.01% 1283
2022
Q2
$497K Buy
+20,045
New +$442K ﹤0.01% 1753

Other funds holding CCXI

Mirae Asset Global Investments's CCXI Position: Q4 2022 in Review

Mirae Asset Global Investments sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 28,531 shares — an estimated $1.47M sold.

Mirae Asset Global Investments first reported a position in CCXI in Q2 2022 and held it in 2 quarters. The position peaked at $1.47M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Mirae Asset Global Investments reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Mirae Asset Global Investments sold 28,531 ChemoCentryx, Inc. shares in Q4 2022, an estimated $1.47M.
  • Mirae Asset Global Investments first reported a position in ChemoCentryx, Inc. in Q2 2022 and held it in 2 quarters.
  • Mirae Asset Global Investments's ChemoCentryx, Inc. position peaked at $1.47M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Mirae Asset Global Investments's 13F filing for Q4 2022, filed 9 Feb 2023.